Government Advisory Panel To Review Covaxin, Corbevax Data For 6-12 Years; Aims To Reduce Booster Dose Gap

New Delhi: Government advisory panel National Technical Advisory Group on Immunisation (NTAGI), will meet on Thursday (June 16) to review data on Covaxin and Corbevax vaccines for the 6-12 age group and also deliberate on reducing the gap between the second and precaution doses from the current nine to six months. The National Technical Advisory Group on Immunisation (NTAGI) will hold its meeting amid a fresh spike in COVID-19 cases in the country. Currently, those aged 12 years and above are vaccinated against COVID-19.

The agenda for the National Technical Advisory Group on Immunisation’s (NTAGI), Standing Technical Sub-Committee (STSC) meeting includes discussion on a study by the CMC Vellore on the feasibility of allowing precaution dose of a COVID-19 vaccine separate from the one used for primary vaccination, the Covid burden in paediatric population, and log-term safety of ZyCoV-D vaccine, official sources said.

India’s drug regulator in April had granted emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech’s Covaxin for children in the age group of six to 12 years.

The Covid Working Group of NTAGI which reviewed the findings of the Christian Medical College (CMC) Vellore study in May had found a lack of uniformity in results upon mixing of jabs for booster shots.

Also Read: COVID-19 Update: New Omicron Subvariants Found In India, What We Know So Far

The study stated that the scientific evidence showed that administering a booster dose of Covishield after primary vaccination with Covaxin gives 6 to 10 times higher antibody level, as compared to when Covaxin is given as the precaution dose after a gap of six months after the primary schedule.

In a statement given to the news agency PTI, an official source said,

However, the same advantage was not observed when Covaxin as a booster shot was given after two Covishield doses.

Considering programmatic challenges, it was decided that the matter would be discussed in the NTAGI’s STSC meeting for final recommendation. Also, the committee in its meeting held in May cited lack of clear evidence of benefit of reducing the interval between last dose of the primary schedule and the protection dose.

It felt that studies presented for the session had valuable scientific information but were not helpful in taking a decision for current policy question.

Also Read: Mumbai Records 1000 Per Cent Rise In Daily COVID Cases In Less Than A Month

The Indian Council of Medical Research (ICMR) was then asked to extract data from the National Vaccine Tracker Platform to determine the breakthrough infection rates at three, six and nine months after completion of the primary schedule before the onset of the Omicron wave and overlapping with the Omicron wave.

It was informed that there is no data available on comparative effectiveness of booster/protection dose administered at six months versus nine months.

Currently, all those above the age of 18 who have completed nine months after the administration of the second dose are eligible for the precaution dose.

The Union government last month allowed citizens and students travelling overseas to get the shot before the stipulated nine-month waiting period as required by the guidelines of the destination country.

Also Read: Anocovax, India’s First COVID-19 Vaccine For Animals: Things You Should Know

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol have been working towards a clean and healthy India since 2014 via the Banega Swachh India initiative, which is helmed by Campaign Ambassador Amitabh Bachchan. The campaign aims to highlight the inter-dependency of humans and the environment, and of humans on one another with the focus on One Health, One Planet, One Future – Leaving No One Behind. It stresses on the need to take care of, and consider, everyone’s health in India – especially vulnerable communities – the LGBTQ population, indigenous people, India’s different tribes, ethnic and linguistic minorities, people with disabilities, migrants, geographically remote populations, gender and sexual minorities. In wake of the current COVID-19 pandemic, the need for WASH (Water, Sanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign will continue to raise awareness on the same along with focussing on the importance of nutrition and healthcare for women and children, fight malnutrition, mental wellbeing, self care, science and health, adolescent health & gender awareness. Along with the health of people, the campaign has realised the need to also take care of the health of the eco-system. Our environment is fragile due to human activity, which is not only over-exploiting available resources, but also generating immense pollution as a result of using and extracting those resources. The imbalance has also led to immense biodiversity loss that has caused one of the biggest threats to human survival – climate change. It has now been described as a “code red for humanity.” The campaign will continue to cover issues like air pollution, waste management, plastic ban, manual scavenging and sanitation workers and menstrual hygiene. Banega Swasth India will also be taking forward the dream of Swasth Bharat, the campaign feels that only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and the country can become a Swasth or healthy India.